LanZhou University and Beijing Normal University
When Minling Hu decided to pursue a Ph.D., she knew early on that she wanted to be a part of the supportive and inspiring research community at GSSIMR. She moved to Kansas City in 2017 and worked in the Halfmann Lab as a research technician for two years, giving her an in-depth look at Stowers.
Hu grew up in Xi’an, China. She went to LanZhou University for a B.S. in life science and technology, then to a master’s program at Beijing Normal University focused on translational medicine. During her time in the lab of Qun Wei, Ph.D., she found a small recombinant protein subunit that can be used as an adjuvant for the hepatitis B vaccine.
Following that, she worked at the Institute of Biophysics and was actively involved in two projects about liver cancer and lipid metabolism. Her passion for translational medicine then took her to the Novo Nordisk Research Center, China, for research on long-acting insulin development.
While at GSSIMR, Hu wants to delve deeper into the fundamental questions of cell biology and molecular biology. She especially likes to work with yeast, since so many significant discoveries in cell biology have come from yeast, and mice, which “are the workhorse for translational medicine.”
After completing her Ph.D. and postdoc, Hu plans to continue her work in translational medicine by becoming an independent investigator in medical research. In her free time, Hu is a big fan of yoga and badminton and believes the two exercises complement each other perfectly.